MDxHealth is trading at $0.65, up +7.72% in pre-market; no clear catalyst was identified.

  • No company-specific announcement, earnings release, regulatory action, or analyst catalyst was identified for September 22, 2026.
  • Broader markets are only modestly higher, so global sentiment does not clearly explain the move.
  • Recent reports reference interim results and analyst valuation changes, but neither directly establishes today’s gain; lower liquidity may increase volatility.